There were no significant differences in tumor features, EGFR mutations, and overall survival between CPFE patients and isolated IPF patients with LC in this study, which was in accordance with Yuji Minegishi et al.’s study [14]. The gene discussed is EGFR; the disease is laryngotracheoesophageal cleft.